Literature DB >> 25408490

Adjusting relative survival estimates for cancer mortality in the general population.

Larry F Ellison1.   

Abstract

BACKGROUND: In theory, expected survival probabilities used in the derivation of relative survival ratios (RSR) are determined from a control group free of the cancer under study. In practice, expected survival is typically estimated from general population life tables--which include people previously diagnosed with cancer--potentially leading to an overestimation of relative survival. DATA AND METHODS: Data are from the Canadian Cancer Registry with mortality follow-up through record linkage to the Canadian Vital Statistics Death Database. Period method RSRs for 2006-to-2008 were derived using general population life tables adjusted for cancer mortality and then compared with estimates derived using corresponding unadjusted life tables.
RESULTS: For all cancers combined, the use of general population life tables to derive expected survival probabilities overestimated RSRs by 0.6 (1-year), 2.4 (5-year) and 4.6 (10-year) percentage units. Biases in 5-year survival were highest among males (3.0) and among people aged 75 to 99 at diagnosis (4.1). The bias was negligible for most individual cancers; biases were highest for prostate cancer, followed by colorectal and female breast cancer.
INTERPRETATION: Canadian estimates of relative survival for all cancers combined calculated using general life tables warrant adjustment for cancer mortality. Consideration of adjustment for cancer mortality is recommended for estimates of colorectal, female breast and especially prostate cancer.

Entities:  

Keywords:  Bias; epidemiologic methods; life tables; neoplasms; registries; survival

Mesh:

Year:  2014        PMID: 25408490

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  6 in total

Review 1.  Composite Tissue Transplant of Hand or Arm: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-06-01

2.  Reporting net survival in populations: a sensitivity analysis in lung cancer demonstrates the differential implications of reporting relative survival and cause-specific survival.

Authors:  Kay See Tan; Takashi Eguchi; Prasad S Adusumilli
Journal:  Clin Epidemiol       Date:  2019-09-02       Impact factor: 4.790

3.  Errors in determination of net survival: cause-specific and relative survival settings.

Authors:  Chloe J Bright; Adam R Brentnall; Kate Wooldrage; Jonathon Myles; Peter Sasieni; Stephen W Duffy
Journal:  Br J Cancer       Date:  2020-02-10       Impact factor: 7.640

4.  Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma.

Authors:  Avram Denburg; Petros Pechlivanoglou; Juan David Rios; Russanthy Velummailum; Julie Bennett; Liana Nobre; Derek S Tsang; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  BMC Pediatr       Date:  2022-01-03       Impact factor: 2.125

Review 5.  Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.

Authors:  Yufei Jiang; Huiyun Yuan; Zhuoying Li; Xiaowei Ji; Qiuming Shen; Jiayi Tuo; Jinghao Bi; Honglan Li; Yongbing Xiang
Journal:  Cancer Biol Med       Date:  2021-09-06       Impact factor: 4.248

6.  Marginal measures and causal effects using the relative survival framework.

Authors:  Elisavet Syriopoulou; Mark J Rutherford; Paul C Lambert
Journal:  Int J Epidemiol       Date:  2020-04-01       Impact factor: 7.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.